The acute assessment of MRgFUS therapies with metrics such as thermal dose and contrast-enhanced (CE) imaging have been shown to under- or over-estimate the final ablation lesion as assessed by delayed imaging or histological outcomes. The aim of this study is to longitudinally register MRgFUS treatment images to a final lesion outcome as determined by CE-T1w imaging three days post-treatment for voxel-wise analysis of these errors. MR thermometry (MRTI), cumulative thermal dose (CTD), and acute CE-T1w images are co-registered to Day 3 CE-T1w with millimeter accuracy and assessed for their predictive value.
A longitudinal assessment of MRgFUS ablations was performed in New Zealand white rabbits (n=3). For an in vivo tumor model, a cell suspension of VX2 (~1x106 cells in 50% media/Matrigel) was injected intramuscularly into the quadriceps muscles and grown for 1-2 weeks. MRgFUS thermal ablation of the tumors and surrounding muscle tissue was performed with a 256-element phased-array transducer (IGT/Imasonic; 10-cm focal length, 14.4 × 9.8 cm aperture, 940 kHz) inside a 3T scanner (PrismaFIT, Siemens), with real-time PRF MR temperature imaging (MRTI, Table 1). Each rabbit was positioned on its side on top a custom-built table, with the target leg partially suspended above the transducer (Figure 1). Multi-parametric MR imaging was acquired pre- and post-ablation, and a high-resolution CE-T1w (Multihance, 0.1 mmol/kg, Table 1) scan was acquired 40 minutes post-ablation (acute). Three days after treatment (Day 3), the CE-T1w scan was re-acquired with the animal in the same position.
Longitudinal Registration: To register all MR scans, 0.5-mm isotropic T1w images acquired pre-ablation and on Day 3 were registered to post-ablation T1w target volume using intensity-based elastic registration [4]. Inter-day registration required a preliminary rigid registration step, using 5-6 femur landmarks in PETRA images. The resulting deformations were applied to the MRTI and Day 3 CE-T1w images to bring all images into a common space. Registration accuracy was assessed with the Euclidean distance between two registered volumes of anatomical landmarks in the quadriceps muscle that are apparent only in the T2w (1.0 mm-isotropic, n=3) images, and not in the non-contrast T1w images.
Image Processing: Acute and Day 3 CE-T1w NPV volumes were semi-automatically segmented by 1) manually drawing volume of interest (VOI) encompassing the NPV and enhancing rim then 2) automatically classifying VOI voxels with SpostCE ≥ SpreCE + 2*σpreCE as “enhancing,” and remaining voxels as “NPV”[5]. The CTD volume for each animal was calculated by summing the thermal dose of each sonication, calculated from the PRF MRTI phase images [6], [7]. CTD240 is the CTD volume thresholded at 240 CEM@43°C.
[1] B. Z. Fite, A. Wong, Y. Liu, L. M. Mahakian, S. M. Tam, O. Aina, N. E. Hubbard, A. Borowsky, R. D. Cardiff, and E. Dumont, “Magnetic Resonance Imaging Assessment of Effective Ablated Volume following High Intensity Focused Ultrasound,” PLoS One, pp. 1–16, 2015.
[2] J. W. Wijlemans, R. Deckers, Þ. M. A. A. J. Van Den Bosch, B. A. Seinstra, M. Van Stralen, Þ. P. J. Van Diest, C. T. W. Moonen, and L. W. Bartels, “Evolution of the Ablation Region After Magnetic Resonance Y Guided High-Intensity Focused Ultrasound Ablation in a Vx2 Tumor Model,” Invest. Radiol., vol. 48, no. 6, pp. 381–386, 2013.
[3] A. Boyesa, K. Tanga, R. Chopra, and M. Bronskill, “Histological evaluation of prostate tissue response to image-guided transurethral thermal therapy after a 48h recovery period,” AIP Conf. Proc., vol. 1113, pp. 111–115, 2009.
[4] R. Bajcsy and Stane Kovačič, “Multiresolution elastic matching,” Comput. Vision, Graph. Image Process., vol. 46, no. 1, pp. 1–21, 1989.
[5] S. J. C. G. Hectors, I. Jacobs, C. T. W. Moonen, G. J. Strijkers, and K. Nicolay, “MRI Methods for the Evaluation of High Intensity Focused Ultrasound Tumor Treatment : Current Status and Future Needs,” Magn. Reson. Med., vol. 317, pp. 302–317, 2016.
[6] V. Rieke and K. B. Pauly, “MR thermometry,” J. Magn. Reson. Imaging, vol. 27, no. 2, pp. 376–390, 2008.
[7] S. A. Sapareto and W. C. Dewey, “Thermal Dose Determination in Cancer Therapy,” Int. J. Radiat. Oncol. Biol. Phys., vol. 10, no. 6, pp. 787–800, 1984.